Literature DB >> 7561388

On the reaction kinetics of the radioadaptive response in cultured mouse cells.

M S Sasaki1.   

Abstract

The reaction kinetics of radioadaptive response of low doses of X-rays have been studied in quiescent cultured mouse cells. Mouse m5S cells pre-exposed in G1 to low doses of X-rays became insensitive to the induction of chromosome aberrations, mutation toward 6-thioguanine resistance, and cell killing. Adapted cells were, however, more susceptible to morphological transformation by subsequent high challenging doses of X-rays. The cytogenetic adaptation, which lasted about 20 h pertained to a narrow dose range. X-ray doses below and above 0.1 Gy appeared to be recognized as different signals; higher doses of X-rays were incapable of inducing adaptation and rapidly extinguished the adapted condition. Treatment with 12-O-tetradecanoyl-phorbol 13-acetate (TPA) and hydrogen peroxide, but not the xanthine/xanthine oxidase superoxide-generating system, mimicked X-rays in inducing adaptation when applied at low doses. Over-exposure to TPA or inhibitors of protein kinase C (PKC) abrogated the adaptive response to X-rays, providing evidence for the involvement of a PKC-mediated signalling pathway. The lack of radioadaptive response in a tumorigenic variant, clone 6110, and its restoration in the morphological revertant obtained by introducing human chromosome 11 further suggested that interference of signalling pathways may alter radioadaptive responses in malignant cells.

Entities:  

Mesh:

Year:  1995        PMID: 7561388     DOI: 10.1080/09553009514551211

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  13 in total

1.  The effects of Fhit on tumorigenesis after multi-exposure to low-dose radiation.

Authors:  Xiaoyan Yu; Lin Lu; Siyuan Wen; Ya Wang
Journal:  Int J Clin Exp Med       Date:  2009-11-22

Review 2.  Role of High-Linear Energy Transfer Radiobiology in Space Radiation Exposure Risks.

Authors:  Akihisa Takahashi; Hiroko Ikeda; Yukari Yoshida
Journal:  Int J Part Ther       Date:  2018-09-21

3.  Immunological mechanism of low-dose priming radiation resistance in walker-256 tumor model mice.

Authors:  Li Feng; Ling Qin; Dan Guo; Daping Deng; Feng Lu; Hailiang Li; Narisu Bao; Xiting Yang; Hongyu Ding; Jianguo Li
Journal:  Exp Ther Med       Date:  2017-08-21       Impact factor: 2.447

Review 4.  Radioadaptive response revisited.

Authors:  Soile Tapio; Vesna Jacob
Journal:  Radiat Environ Biophys       Date:  2006-11-28       Impact factor: 1.925

5.  The Ku-dependent non-homologous end-joining pathway contributes to low-dose radiation-stimulated cell survival.

Authors:  Xiaoyan Yu; Hongyan Wang; Ping Wang; Benjamin P C Chen; Ya Wang
Journal:  J Cell Physiol       Date:  2011-02       Impact factor: 6.384

Review 6.  Cancer risk at low doses of ionizing radiation: artificial neural networks inference from atomic bomb survivors.

Authors:  Masao S Sasaki; Akira Tachibana; Shunichi Takeda
Journal:  J Radiat Res       Date:  2013-12-22       Impact factor: 2.724

7.  Adaptive doses of irradiation-an approach to a new therapy concept for bladder cancer?

Authors:  Moshe Schaffer; Silke B Schwarz; Ulrike Kulka; Martin Busch; Eckhart Dühmke
Journal:  Radiat Environ Biophys       Date:  2004-09-29       Impact factor: 1.925

8.  Unstable chromosome aberrations do not accumulate in normal human fibroblast after fractionated x-irradiation.

Authors:  Mitsuaki Ojima; Maki Ito; Keiji Suzuki; Michiaki Kai
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

9.  Role of heme Oxygenase-1 in low dose Radioadaptive response.

Authors:  Lingzhi Bao; Jie Ma; Guodong Chen; Jue Hou; Tom K Hei; K N Yu; Wei Han
Journal:  Redox Biol       Date:  2016-03-03       Impact factor: 11.799

10.  The effect of radio-adaptive doses on HT29 and GM637 cells.

Authors:  Silke B Schwarz; Pamela M Schaffer; Ulrike Kulka; Birgit Ertl-Wagner; Roswitha Hell; Moshe Schaffer
Journal:  Radiat Oncol       Date:  2008-04-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.